Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways.
Clin Pharmacol Ther
; 100(6): 730-742, 2016 12.
Article
en En
| MEDLINE
| ID: mdl-27626221
ABSTRACT
Earlier patient access to beneficial therapeutics that addresses unmet need is one of the main requirements of innovation in global healthcare systems already burdened by unsustainable budgets. "Adaptive pathways" encompass earlier cross-stakeholder engagement, regulatory tools, and iterative evidence generation through the life cycle of the medicinal product. A key enabler of earlier patient access is through more flexible and adaptive payer approaches to pricing and reimbursement that reflect the emerging evidence generated.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Mecanismo de Reembolso
/
Atención a la Salud
/
Accesibilidad a los Servicios de Salud
/
Necesidades y Demandas de Servicios de Salud
Tipo de estudio:
Health_economic_evaluation
/
Sysrev_observational_studies
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Clin Pharmacol Ther
Año:
2016
Tipo del documento:
Article
País de afiliación:
Reino Unido